{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:31:33Z","timestamp":1768883493374,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010156.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000}}],"reference-count":69,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010156.pub3","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T17:46:38Z","timestamp":1636739198000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dietary supplements for chronic gout"],"prefix":"10.1002","volume":"2022","author":[{"given":"Mariano","family":"Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Reumatolog\u00eda; Hospital General Universitario de Alicante; Alicante Spain"},{"name":"Departamento de Medicina Cl\u00ednica; Universidad Miguel Hern\u00e1ndez; Elche Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Sivera","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Cl\u00ednica; Universidad Miguel Hern\u00e1ndez; Elche Spain"},{"name":"Servicio de Reumatologia; Hospital de Elda; Elda (Alicante) Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University; Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology; Cabrini Health; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Pardo Pardo","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, The Ottawa Hospital - General Campus; Ottawa Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[{"name":"Instituto de Salud Musculoesquel\u00e9tica; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"10.1002\/14651858.CD010156.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2011-200156","article-title":"Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial","volume":"71","author":"Dalbeth","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"SUPPL. 10","key":"10.1002\/14651858.CD010156.pub3-BIB0002|cit2","first-page":"207","article-title":"Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial","volume":"63","author":"Kuhn-Sherlock","year":"2011","journal-title":"Arthritis and Rheumatism"},{"issue":"SUPPL. 10","key":"10.1002\/14651858.CD010156.pub3-BIB0003|cit3","first-page":"S60","article-title":"Lack of effect of supplemental vitamin C on serum urate in patients with gout","volume":"64","year":"2012","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD010156.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.37925","article-title":"Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial","volume":"65","author":"Stamp","year":"2013","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010156.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3899\/jrheum.190974","article-title":"Epidemiology of Depression and Anxiety in Gout: A Systematic Review and Metaanalysis","volume":"48","author":"Howren","year":"2021","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010156.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.semarthrit.2019.11.002","article-title":"How flare prevention outcomes are reported in gout studies: A systematic review and content analysis of randomized controlled trials","volume":"50","author":"Stewart","year":"2020","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010156.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14397595.2018.1442183","article-title":"Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and\/or gout: a randomised, double-blind, placebo-controlled study","volume":"29","author":"Yamanaka","year":"2019","journal-title":"Modern Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010156.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jbspin.2019.03.003","article-title":"Associations of hyperuricemia, gout, and UA-lowering therapy with the risk of fractures: A meta-analysis of observational studies","volume":"86","author":"Zong","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010156.pub3-BIB0009|cit9","first-page":"218","article-title":"Hepatoprotective properties of artichoke (cynara scolymus L) in patients with gout and hepatobiliary system pathology","volume":"15","author":"Arych","year":"2010","journal-title":"European Journal of Medical Research"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0010|cit10","unstructured":"A randomized controlled trial of of krill oil on ultrasound detected inflammation in people with gout www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=373777"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0011|cit11","unstructured":"The efficacy of celery seed extract in patients with primary gout: a randomized controlled trial www.chictr.org.cn\/showprojen.aspx?proj=34732"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0012|cit12","unstructured":"Omega\u20133 fatty acids for the prophylaxis of acute attacks of gout on initiating urate-lowering treatment \u2013 a feasibility study for a randomised controlled trial (SOGAS) www.isrctn.com\/ISRCTN79392964 10.1186\/ISRCTN79392964"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0013|cit13","unstructured":"The effect of tart cherry juice on risk of gout attacks clinicaltrials.gov\/ct2\/show\/NCT03621215"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0014|cit14","unstructured":"Pharmacokinetics and pharmacodynamics of anthocyanins clinicaltrials.gov\/ct2\/show\/NCT03650140"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0015|cit15","unstructured":"Probiotics for gout\/hyperuricemia: randomized, double-blind, intervention, parallel controlled, multicenter clinicaltrials.gov\/ct2\/show\/NCT04199325"},{"issue":"1","key":"10.1002\/14651858.CD010156.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-9343(77)90351-5","article-title":"The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid","volume":"62","author":"Berger","year":"1977","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1445-5994.2002.00213.x","article-title":"Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice","volume":"32","author":"Buchbinder","year":"2002","journal-title":"Internal Medicine Journal"},{"issue":"3","key":"10.1002\/14651858.CD010156.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"427-34","DOI":"10.1002\/acr.23607","article-title":"Gout, Hyperuricemia, and Crystal-Associated Disease Network consensus statement regarding Labels and definitions for disease elements in gout","volume":"71","author":"Bursill","year":"2019","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0019|cit19","unstructured":"Cates C Visual Rx Version 3 www.nntonline.net\/visualrx\/"},{"issue":"4","key":"10.1002\/14651858.CD010156.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.joca.2007.10.003","article-title":"Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials","volume":"16","author":"Christensen","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0021|cit21","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"issue":"4","key":"10.1002\/14651858.CD010156.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/ard.2009.113290","article-title":"Identification of dairy fractions with anti-inflammatory properties in models of acute gout","volume":"69","author":"Dalbeth","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0023|cit23","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0024|cit24","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0025|cit25","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0026|cit26","unstructured":"Higgins JPT Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD010156.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/art.21105","article-title":"The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial","volume":"52","author":"Huang","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"9","key":"10.1002\/14651858.CD010156.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/acr.20519","article-title":"Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials","volume":"63","author":"Juraschek","year":"2011","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-62-4-639","article-title":"The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout","volume":"62","author":"Klinenberg","year":"1965","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1439-0396.2011.01191.x","article-title":"The effect of depurinized milk draught diet on rat serum uric acid, lipid status and haematological parameters","volume":"96","author":"Kocic","year":"2012","journal-title":"Journal of Animal Physiology and Animal Nutrition"},{"issue":"10","key":"10.1002\/14651858.CD010156.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.168.10.1104","article-title":"Long-term cardiovascular mortality among middle-aged men with gout","volume":"168","author":"Krishnan","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010156.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/rheumatology\/kep364","article-title":"Gout: an independent risk factor for all-cause and cardiovascular mortality","volume":"49","author":"Kuo","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1002\/14651858.CD010156.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1017\/S0007114510000310","article-title":"Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats","volume":"104","author":"Lo","year":"2010","journal-title":"British Journal of Nutrition"},{"issue":"16","key":"10.1002\/14651858.CD010156.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2165\/11202830-000000000-00000","article-title":"Pegloticase: in treatment-refractory chronic gout","volume":"71","author":"Lyseng-Williamson","year":"2011","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD010156.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/clpt.1981.42","article-title":"Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects","volume":"29","author":"Mitch","year":"1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD010156.pub3-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010039.pub2","article-title":"Lifestyle interventions for chronic gout","author":"Moi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010156.pub3-BIB0038|cit38","first-page":"95","article-title":"The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans","volume":"9","author":"Mori","year":"2006","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/ndt\/12.9.1832","article-title":"Uric acid nephropathy and end-stage renal disease \u2013 review of a non-disease","volume":"12","author":"Nickeleit","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0040|cit40","unstructured":"Page MJ Higgins JPT Sterne JAC Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD010156.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010156.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2006.060368","article-title":"Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout","volume":"66","author":"Pascual","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2217\/ijr.09.5","article-title":"Gout: new advances on diagnosis and management of an old disease","volume":"4","author":"Pascual","year":"2009","journal-title":"International Journal of Clinical Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010156.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd2831","article-title":"Febuxostat","volume":"8","author":"Pascual","year":"2009","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1002\/14651858.CD010156.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/RHU.0b013e3182314d40","article-title":"An audit of the variability of diagnosis and management of gout in the rheumatology setting: the Gout Evaluation and Management study","volume":"17","author":"Perez-Ruiz","year":"2011","journal-title":"Journal of Clinical Rheumatology"},{"issue":"15","key":"10.1002\/14651858.CD010156.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archinternmed.2010.254","article-title":"Effect of enzyte on QT and QTc intervals","volume":"170","author":"Philips","year":"2010","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0048|cit48","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"issue":"9711","key":"10.1002\/14651858.CD010156.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010156.pub3-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD010156.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0049-0172(75)90002-5","article-title":"Gout in Maoris","volume":"5","author":"Rose","year":"1975","journal-title":"Seminars of Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ije\/14.1.32","article-title":"Sick individuals and sick populations","volume":"14","author":"Rose","year":"1985","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2474-12-21","article-title":"Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France","volume":"12","author":"Rossignol","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"10","key":"10.1002\/14651858.CD010156.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0055|cit55","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0056|cit56","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JPT Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD010156.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006077.pub3","article-title":"Allopurinol for chronic gout","author":"Seth","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010156.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.berh.2010.10.004","article-title":"Epidemiology of gout: an update","volume":"24","author":"Smith","year":"2010","journal-title":"Best Practice and Research Clinical Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD010156.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semarthrit.2010.09.003","article-title":"Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfils the OMERACT validation criteria for soluble biomarkers","volume":"40","author":"Stamp","year":"2011","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.7326\/0003-4819-84-4-385","article-title":"Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy","volume":"84","author":"Stein","year":"1976","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010156.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1478-3231.2010.02439.x","article-title":"Review of liver injury associated with dietary supplements","volume":"31","author":"Stickel","year":"2011","journal-title":"Liver International"},{"issue":"3","key":"10.1002\/14651858.CD010156.pub3-BIB0062|cit62","first-page":"528","article-title":"OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction","volume":"20","author":"Tugwell","year":"1993","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010156.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1756-185X.2011.01619.x","article-title":"What about supplements for osteoarthritis? A critical and evidence-based review","volume":"14","author":"Vista","year":"2011","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010156.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1090820X12438913","article-title":"Bleeding risks of herbal, homeopathic, and dietary supplements: a hidden nightmare for plastic surgeons?","volume":"32","author":"Wong","year":"2012","journal-title":"Aesthetic Surgery Journal"},{"issue":"11","key":"10.1002\/14651858.CD010156.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.clinthera.2011.09.024","article-title":"Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys","volume":"33","author":"Wu","year":"2011","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"7976130","DOI":"10.1155\/2020\/7976130","article-title":"The impact of natural product dietary supplements on patients with gout: a systematic review and meta-analysis of randomized controlled trials","volume":"2020","author":"Yang","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine: ECAM"},{"key":"10.1002\/14651858.CD010156.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0049-0172(84)90016-7","article-title":"Diversity of gouty features in gouty arthritis","volume":"13","year":"1984","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD010156.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","article-title":"Vitamin D inhibits monocyte\/macrophage pro-inflammatory cytokine production by targeting MAPK phosphatase-1","volume":"188","author":"Zhang","year":"2012","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1002\/14651858.CD010156.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010156.pub2","article-title":"Dietary supplements for chronic gout","author":"Andr\u00e9s","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:17:31Z","timestamp":1761254251000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010156.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010156.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]}}}